Calcium Myotonic dystrophy Motoneuron Autoimmunity Cell therapy CTG repeat contractions Lamin A/C LMNA gene Mice Fabry disease Inflammation Brain Male MBNL Therapy Neuromuscular disease Autophagy Transcriptomics Exercise Actin Gene therapy Aging LMNA CMS Lamin A/C Regeneration Duchenne muscular dystrophy Myasthenia Gravis MG Myogenesis COVID-19 Thérapie génique OPMD Genetics Nuclear envelope Rare diseases Animals Errance diagnostique Laminopathy Dermatomyositis AAV CRISPRi Satellite cell Myotonic dystrophy type 1 Mechanotransduction RNA biology Glutamate Myopathy Myoblasts Humans Treatment Long read sequencing Cytokines Genotype phenotype correlation Alternative splicing Autoimmune diseases Mouse model Heart PABPN1 Biomarker Skeletal muscle Becker muscular dystrophy Myopathies LMNA gene Biomarkers Centronuclear myopathy Trinucleotide repeat expansion Aged Fibrosis Myotonic Dystrophy type 1 Dilated cardiomyopathy Dystrophin Muscle ALS Astrocyte Cardiomyopathy RNA interference Rare neuromuscular diseases Muscle regeneration Myotonic Dystrophy Neuromuscular junction Congenital myopathy Cytoskeleton Thymus Neuromuscular diseases Outcome measures Spinal muscular atrophy Antisense oligonucleotides Myositis DMD Laminopathie Transgenic mouse model FSHD Satellite cells Congenital muscular dystrophy Amyotrophic lateral sclerosis Autoantibodies Myasthenia gravis Dynamin 2 Muscular dystrophy Laminopathies Heart failure